Which statement about estrogen use in postmenopausal continence is true?

Which statement about estrogen use in postmenopausal continence is true?

• A. Systemic estrogen is routinely used to treat UI
• B. Local estrogen may worsen urethral mucosa
• C. Systemic estrogen is the only recommended therapy for UI
• D. Local estrogen may improve urethral mucosa

Answer: (D)

Estrogen helps by improving tissue health where it matters for continence. In postmenopausal women, thinning and drying of the urethral and vaginal mucosa can weaken the barrier and mucosal support that help keep urine in. Local estrogen applied vaginally or to the periurethral area directly nourishes these tissues, thickening and improving mucosal integrity, blood flow, and lubrication. This can enhance urethral coaptation and reduce symptoms related to urinary leakage. Systemic estrogen, on the other hand, has not shown consistent benefit for urinary incontinence and carries broader risks, so it is not routinely used for UI. The option that local estrogen may improve urethral mucosa captures the targeted, tissue-level benefit that actually helps with continence in this context.

Estrogen helps by improving tissue health where it matters for continence. In postmenopausal women, thinning and drying of the urethral and vaginal mucosa can weaken the barrier and mucosal support that help keep urine in. Local estrogen applied vaginally or to the periurethral area directly nourishes these tissues, thickening and improving mucosal integrity, blood flow, and lubrication. This can enhance urethral coaptation and reduce symptoms related to urinary leakage.

Systemic estrogen, on the other hand, has not shown consistent benefit for urinary incontinence and carries broader risks, so it is not routinely used for UI. The option that local estrogen may improve urethral mucosa captures the targeted, tissue-level benefit that actually helps with continence in this context.